Associations of classic Kaposi sarcoma with common variants in genes that modulate host immunity

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 5, 2006, Pages 926-934

  Brown, Elizabeth E ^a,b   Fallin, Daniele ^b   Ruczinski, Ingo ^b   Hutchinson, Amy ^c   Staats, Brian ^c   Vitale, Francesco ^d   Lauria, Carmela ^e   Serraino, Diego ^f   Rezza, Giovanni ^g   Mbisa, Georgina ^c   Whitby, Denise ^a,c   Messina, Angelo ^h   Goedert, James J ^a   Chanock, Stephen J ^a,c   Romano, Nino ^d   Ajello, Francesca ^d   Bonura, Filippa ^d   Perna, Anna Maria ^d   Viviano, Enza ^d   Tramuto, Fabio ^d   Villafrate, Maria Rosaria ^d   Di Benedetto, Maria Antonella ^d   Tamburini, Mario ⁱ   Montella, Mauizio ⁱ   Crispo, Anna ⁱ   de Sicato, Sonia ⁱ   de Marco, Maria Rosaria ⁱ   Ascierto, Paolo ⁱ   Piselli, Pierluca ^j   Valdarchi, Catia ^g   Farchi, Francesca ^g   Corona, Rosa Maria ^k   Di Carlo, Aldo ^l   Castilletti, Concetta ^l   Gafa, Lorenzo ^e   Stella, Stefania ^h   Massimino, Michele ^h   Kroner, Barbara ^m   Chatterjee, Nilanjan ^a   Chen, Jinbo ^a   Kiley, Maureen ^a   Chen, Renee ^a   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c SAIC FREDERICK INC   (United States)

^d UNIVERSITY OF PALERMO   (Italy)

^e Sez Provinciale di Ragusa   (Italy)

^f CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^g ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^h UNIVERSITY OF CATANIA   (Italy)

ⁱ NATIONAL CANCER INSTITUTE   (Italy)

^j NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^k LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^l SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

^m RTI INTERNATIONAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ARTICLE; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; DNA EXTRACTION; FEMALE; HAPLOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; ITALY; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION;

EID: 33744813534     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0791     Document Type: Article

References (100)

1. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 1994;266: 1865-9.
2. Schalling M, Ekman M, Kaaya EE, Linde A, Biberfeld P. A role for a new herpes virus (KSHV) in different forms of Kaposi’s sarcoma. Nat Med 1995; 1:707-8.
3. Kaposi M. Idiopathisches multiples pigmentsarkom der haut. Arch f Dermat u Syph 1872;4:265-73.
4. Oettle A. Geographical and racial differences in the frequency of Kaposi’s sarcoma as evidence of environmental or genetic causes. Acta Un Int Cancer 1962;18:330-63.
5. Myers BD, Kessler E, Levi J, Pick A, Rosenfeld JB, Tikvah P. Kaposi sarcoma in kidney transplant recipients. Arch Intern Med 1974;133:307-11.
6. Pneumocystis pneumonia among homosexual men: New York City and California. MMWR MOrb Mortal Wkly Rep 1981;30:305-8.
7. Whitby D, Luppi M, Barozzi P, Boshoff C, Weiss RA, Torelli G. Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy. J Natl Cancer Inst 1998;90:395-7.
8. Friedman-Kien AE. Disseminated Kaposi’s sarcoma syndrome in young homosexual men. J Am Acad Dermatol 1981;5:468-71.
9. Gottlieb GJ, Ackerman AB. Kaposi’s sarcoma: an extensively disseminated form in young homosexual men. Hum Pathol 1982;13:882-92.
10. McNutt NS, Fletcher V, Conant MA. Early lesions of Kaposi’s sarcoma in homosexual men. An ultrastructural comparison with other vascular proliferations in skin. Am J Pathol 1983;111:62-77.
11. Tabata M, Langford A, Becker J, Reichart PA. Distribution of immunocompetent cells in oral Kaposi’s sarcoma (AIDS). Eur J Cancer B Oral Oncol 1993; 29B:209-13.
12. Uccini S, Ruco LP, Monardo F, et al. Co-expression of endothelial cell and macrophage antigens in Kaposi’s sarcoma cells. J Pathol 1994;173: 23-31.
13. Regezi JA, MacPhail LA, Daniels TE, DeSouza YG, Greenspan JS, Greenspan D. Human immunodeficiency virus-associated oral Kaposi’s sarcoma. A heterogeneous cell population dominated by spindle-shaped endothelial cells. Am J Pathol 1993;143:240-9.
14. MacPhail LA, Dekker NP, Regezi JA. Macrophages and vascular adhesion molecules in oral Kaposi’s sarcoma. J Cutan Pathol 1996;23:464-72.
15. Galea P, Frances V, Dou-Dameche L, Sampol J, Chermann JC. Role of Kaposi’s sarcoma cells in recruitment of circulating leukocytes: implications in pathogenesis. J Hum Virol 1998;1:273-81.
16. Ganem D. KSHV and Kaposi’s sarcoma: the end of the beginning? Cell 1997; 91:157-60.
17. Moore PS, Boshoff C, Weiss RA, Chang Y. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 1996;274: 1739-44.
18. Cesarman E, Nador RG, Bai F, et al. Kaposi’s sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi’s sarcoma and malignant lymphoma. J Virol 1996;70:8218-23.
19. Arvanitakis L, Geras-Raaka E, Varma A, Gershengorn MC, Cesarman E. Human herpesvirus KSHV encodes a constitutively active G-proteincoupled receptor linked to cell proliferation. Nature 1997;385:347-50.
20. Neipel F, Albrecht JC, Ensser A, et al. Human herpesvirus 8 encodes a homolog of interleukin-6. J Virol 1997;71:839-42.
21. Guo HG, Browning P, Nicholas J, et al. Characterization of a chemokine receptor-related gene in human herpesvirus 8 and its expression in Kaposi’s sarcoma. Virology 1997;228:371-8.
22. Ensoli B, Nakamura S, Salahuddin SZ, et al. AIDS-Kaposi’s sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science 1989;243:223-6.
23. Barillari G, Buonaguro L, Fiorelli V, et al. Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi’s sarcoma pathogenesis. J Immunol 1992; 149:3727-34.
24. Miles SA, Rezai AR, Salazar-Gonzalez JF, et al. AIDS Kaposi sarcomaderived cells produce and respond to interleukin 6. Proc Natl Acad Sci U S A 1990;87:4068-72.
25. Yang J, Hagan MK, Offermann MK. Induction of IL-6 gene expression in Kaposi’s sarcoma cells. J Immunol 1994;152:943-55.
26. Nair BC, DeVico AL, Nakamura S, et al. Identification of a major growth factor for AIDS-Kaposi’s sarcoma cells as oncostatin M. Science 1992;255: 1430-2.
27. Samaniego F, Markham PD, Gallo RC, Ensoli B. Inflammatory cytokines induce AIDS-Kaposi’s sarcoma-derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi’s sarcoma-like lesion formation in nude mice. J Immunol 1995;154:3582-92.
28. Samaniego F, Markham PD, Gendelman R, Gallo RC, Ensoli B. Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi’s sarcoma-like lesions in nude mice. J Immunol 1997;158:1887-94.
29. Brockmeyer NH, Willers CP, Anders S, Mertins L, Rockstroh JK, Sturzl M. Cytokine profile of HIV-positive Kaposi’s sarcoma derived cells in vitro. Eur J Med Res 1999;4:95-100.
30. Sturzl M, Brandstetter H, Zietz C, et al. Identification of interleukin-1 and platelet-derived growth factor-B as major mitogens for the spindle cells of Kaposi’s sarcoma: a combined in vitro and in vivo analysis. Oncogene 1995;10:2007-16.
31. Oxholm A, Oxholm P, Permin H, Bendtzen K. Epidermal tumour necrosis factor alpha and interleukin 6-like activities in AIDS-related Kaposi’s sarcoma. An immunohistological study. APMIS 1989;97:533-8.
32. Cai J, Gill PS, Masood R, et al. Oncostatin-M is an autocrine growth factor in Kaposi’s sarcoma. Am J Pathol 1994;145:74-9.
33. Fiorelli V, Gendelman R, Samaniego F, Markham PD, Ensoli B. Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi’s sarcoma spindle cells. J Clin Invest 1995;95:1723-34.
34. Ensoli B, Markham P, Kao V, et al. Block of AIDS-Kaposi’s sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS. J Clin Invest 1994;94:1736-46.
35. Ensoli B, Gendelman R, Markham P, et al. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi’s sarcoma. Nature 1994;371:674-80.
36. Cornali E, Zietz C, Benelli R, et al. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi’s sarcoma. Am J Pathol 1996;149:1851-69.
37. Xerri L, Hassoun J, Planche J, et al. Fibroblast growth factor gene expression in AIDS-Kaposi’s sarcoma detected by in situ hybridization. Am J Pathol 1991;138:9-15.
38. Bais C, Santomasso B, Coso O, et al. G-protein-coupled receptor of Kaposi’s sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 1998;391:86-9.
39. Sturzl M, Zietz C, Monini P, Ensoli B. Human herpesvirus-8 and Kaposi’s sarcoma: relationship with the multistep concept of tumorigenesis. Adv Cancer Res 2001;81:125-59.
40. Ensoli B, Sturzl M. Kaposi’s sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents. Cytokine Growth Factor Rev 1998;9:63-83.
41. Thomson A. The cytokine handbook. 3rd ed. San Diego: Academic Press; 1998.
42. Foster CB, Lehrnbecher T, Samuels S, et al. An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus. Blood 2000; 96:2562-7.
43. van der Kuyl AC, Polstra AM, Weverling GJ, Zorgdrager F, van den Burg R, Cornelissen M. An IL-8 gene promoter polymorphism is associated with the risk of the development of AIDS-related Kaposi’s sarcoma: a case-control study. AIDS 2004;18:1206-8.
44. Goedert JJ, Vitale F, Lauria C, et al. Risk factors for classical Kaposi’s sarcoma. J Natl Cancer Inst 2002;94:1712-8.
45. Whitby D, Boshoff C. Kaposi’s sarcoma herpesvirus as a new paradigm for virus-induced oncogenesis. Curr Opin Oncol 1998;10:405-12.
46. de Sanjose S, Marshall V, Sola J, et al. Prevalence of Kaposi’s sarcomaassociated herpesvirus infection in sex workers and women from the general population in Spain. Int J Cancer 2002;98:155-8.
47. Packer BR, Yeager M, Staats B, et al. SNP500Cancer: a public resource for sequence validation and assay development for genetic variation in candidate genes. Nucleic Acids Res 2004;32 Database issue:D528-32.
48. Antonarakis SE. Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group. Hum Mutat 1998; 11:1-3.
49. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002;70:425-34.
50. Lake SL, Lyon H, Tantisira K, et al. Estimation and tests of haplotypeenvironment interaction when linkage phase is ambiguous. Hum Hered 2003;55:56-65.
51. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68:978-89.
52. Stephens M, Donnelly P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003;73: 1162-9.
53. Kooperberg C, Ruczinski I, LeBlanc ML, Hsu L. Sequence analysis using logic regression. Genet Epidemiol 2001;21 Suppl 1:S626-31.
54. Ruczinski I, Kooperberg Cl, LeBlanc M. Logic regression. J Computational and Graphical Statistics 2003;12:475-511.
55. Computing TRPfS. 2.1.0 ed. Available: http://www.r-project.org/; 2005.
56. Abbas AK LAaPJ. Cellular and molecular immunology. 3rd ed. Philadelphia: WB Saunders Co.; 1997.
57. Sirianni MC, Vincenzi L, Fiorelli V, et al. gamma-Interferon production in peripheral blood mononuclear cells and tumor infiltrating lymphocytes from Kaposi’s sarcoma patients: correlation with the presence of human herpesvirus-8 in peripheral blood mononuclear cells and lesional macrophages. Blood 1998;91:968-76.
58. Fiorelli V, Gendelman R, Sirianni MC, et al. gamma-Interferon produced by CD8+ T cells infiltrating Kaposi’s sarcoma induces spindle cells with angiogenic phenotype and synergy with human immunodeficiency virus-1 Tat protein: an immune response to human herpesvirus-8 infection? Blood 1998;91:956-67.
59. O’Brien SJ, Nelson GW. Human genes that limit AIDS. Nat Genet 2004;36: 565-74.
60. Fallin D, Cohen A, Essioux L, et al. Genetic analysis of case/control data using estimated haplotype frequencies: application to APOE locus variation and Alzheimer’s disease. Genome Res 2001;11:143-51.
61. Fallin D, Schork NJ. Accuracy of haplotype frequency estimation for biallelic loci, via the expectation-maximization algorithm for unphased diploid genotype data. Am J Hum Genet 2000;67:947-59.
62. Schwarz M, Murphy PM. Kaposi’s sarcoma-associated herpesvirus G protein-coupled receptor constitutively activates NF-kappa B and induces proinflammatory cytokine and chemokine production via a C-terminal signaling determinant. J Immunol 2001;167:505-13.
63. Arvanitakis L, Mesri EA, Nador RG, et al. Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring kaposi’s sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus. Blood 1996;88:2648-54.
64. Kato H, Tsuchiya N, Tokunaga K. Single nucleotide polymorphisms in the coding regions of human CXC-chemokine receptors CXCR1, CXCR2 and CXCR 3. Genes Immun 2000;1:330-7.
65. Renzoni E, Lympany P, Sestini P, et al. Distribution of novel polymorphisms of the interleukin-8 and CXC receptor 1 and 2 genes in systemic sclerosis and cryptogenic fibrosing alveolitis. Arthritis Rheum 2000;43:1633-40.
66. Hechtman DH, Cybulsky MI, Fuchs HJ, Baker JB, Gimbrone MA, Jr. Intravascular IL-8. Inhibitor of polymorphonuclear leukocyte accumulation at sites of acute inflammation. J Immunol 1991;147:883-92.
67. Colditz I, Zwahlen R, Dewald B, Baggiolini M. In vivo inflammatory activity of neutrophil-activating factor, a novel chemotactic peptide derived from human monocytes. Am J Pathol 1989;134:755-60.
68. Leonard EJ, Skeel A, Yoshimura T, Noer K, Kutvirt S, Van Epps D. Leukocyte specificity and binding of human neutrophil attractant/activation protein-1. J Immunol 1990;144:1323-30.
69. Matsushima K, Morishita K, Yoshimura T, et al. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J Exp Med 1988;167:1883-93.
70. Schroder JM, Mrowietz U, Christophers E. Purification and partial biologic characterization of a human lymphocyte-derived peptide with potent neutrophil-stimulating activity. J Immunol 1988;140:3534-40.
71. Koch AE, Polverini PJ, Kunkel SL, et al. Interleukin-8 as a macrophagederived mediator of angiogenesis. Science 1992;258:1798-801.
72. Murdoch C, Monk PN, Finn A. Cxc chemokine receptor expression on human endothelial cells. Cytokine 1999;11:704-12.
73. Salcedo R, Ponce ML, Young HA, et al. Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood 2000;96:34-40.
74. Li A, Dubey S, Varney ML, Dave BJ, Singh RK. IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 2003;170:3369-76.
75. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol 1994;55:97-179.
76. Gerszten RE, Garcia-Zepeda EA, Lim YC, et al. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 1999;398:718-23.
77. Yoshimura T, Matsushima K, Tanaka S, et al. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci U S A 1987;84: 9233-7.
78. Murphy PM, Tiffany HL. Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 1991;253:1280-3.
79. Holmes WE, Lee J, Kuang WJ, Rice GC, Wood WI. Structure and functional expression of a human interleukin-8 receptor. Science 1991;253:1278-80.
80. Mollereau C, Muscatelli F, Mattei MG, Vassart G, Parmentier M. The highaffinity interleukin 8 receptor gene (IL8RA) maps to the 2q33-36 region of the human genome: cloning of a pseudogene (IL8RBP) for the low-affinity receptor. Genomics 1993;16:248-51.
81. Sprenger H, Lloyd AR, Lautens LL, Bonner TI, Kelvin DJ. Structure, genomic organization, and expression of the human interleukin-8 receptor B gene. J Biol Chem 1994;269:11065-72.
82. Ahuja SK, Shetty A, Tiffany HL, Murphy PM. Comparison of the genomic organization and promoter function for human interleukin-8 receptors A and B. J Biol Chem 1994;269:26381-9.
83. Santamaria Babi LF, Moser B, Perez Soler MT, et al. The interleukin-8 receptor B and CXC chemokines can mediate transendothelial migration of human skin homing T cells. Eur J Immunol 1996;26:2056-61.
84. Bais C, Van Geelen A, Eroles P, et al. Kaposi’s sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/KDR. Cancer Cell 2003;3:131-43.
85. Sodhi A, Montaner S, Patel V, et al. The Kaposi’s sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha. Cancer Res 2000;60:4873-80.
86. Cesarman E, Mesri EA, Gershengorn MC. Viral G protein-coupled receptor and Kaposi’s sarcoma: a model of paracrine neoplasia? J Exp Med 2000;191: 417-22.
87. Montaner S, Sodhi A, Pece S, Mesri EA, Gutkind JS. The Kaposi’s sarcomaassociated herpesvirus G protein-coupled receptor promotes endothelial cell survival through the activation of Akt/protein kinase B. Cancer Res 2001;61: 2641-8.
88. Yang TY, Chen SC, Leach MW, et al. Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi’s sarcoma. J Exp Med 2000; 191:445-54.
89. Pati S, Cavrois M, Guo HG, et al. Activation of NF-kappaB by the human herpesvirus 8 chemokine receptor ORF74: evidence for a paracrine model of Kaposi’s sarcoma pathogenesis. J Virol 2001;75: 8660-73.
90. Gershengorn MC, Geras-Raaka E, Varma A, Clark-Lewis I. Chemokines activate Kaposi’s sarcoma-associated herpesvirus G protein-coupled receptor in mammalian cells in culture. J Clin Invest 1998;102:1469-72.
91. Chiou CJ, Poole LJ, Kim PS, et al. Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi’s sarcoma-associated herpesvirus. J Virol 2002;76:3421-39.
92. Heinzmann A, Mao XQ, Akaiwa M, et al. Genetic variants of IL-13 signalling and human asthma and atopy. Hum Mol Genet 2000;9:549-59.
93. Graves PE, Kabesch M, Halonen M, et al. A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children. J Allergy Clin Immunol 2000;105: 506-13.
94. Wang M, Xing ZM, Lu C, et al. A common IL-13 Arg130Gln single nucleotide polymorphism among Chinese atopy patients with allergic rhinitis. Hum Genet 2003;113:387-90.
95. Minty A, Chalon P, Derocq JM, et al. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993; 362:248-50.
96. Morgan JG, Dolganov GM, Robbins SE, Hinton LM, Lovett M. The selective isolation of novel cDNAs encoded by the regions surrounding the human interleukin 4 and 5 genes. Nucleic Acids Res 1992;20:5173-9.
97. Smirnov DV, Smirnova MG, Korobko VG, Frolova EI. Tandem arrangement of human genes for interleukin-4 and interleukin-13: resemblance in their organization. Gene 1995;155:277-81.
98. McKenzie AN, Culpepper JA, de Waal Malefyt R, et al. Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc Natl Acad Sci U S A 1993;90:3735-9.
99. Monini P, Colombini S, Sturzl M, et al. Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi’s sarcoma. Blood 1999;93:4044-58.
100. Blasig C, Zietz C, Haar B, et al. Monocytes in Kaposi’s sarcoma lesions are productively infected by human herpesvirus 8. J Virol 1997;71:7963-8.